AMS Health Sciences, Inc. Announces Third Quarter 2005 Financial Results
17 Novembre 2005 - 10:00PM
Business Wire
AMS Health Sciences, Inc., (Amex:AMM), today announced a net loss
for the third quarter 2005 of $513,868, or $(0.07) per common
(diluted) share, on 7.5 million shares outstanding, compared to a
net loss of $1,021,657, or $(0.15) per common (diluted) share, on
6.9 million shares outstanding in the third quarter of 2004. Sales
totaled $2.9 million for the quarter compared to sales of $4.5
million for the quarter ended September 30, 2004. Cash, Marketable
Securities and Trade Receivables at September 30, 2005 totaled $1.7
million compared to $3.6 million at December 31, 2004. The quick
ratio of assets to liabilities was approximately 2:1, compared to
3:1 at December 31, 2004, while shareholders' equity at September
30, 2005 was $3.4 million compared to shareholders' equity of $6.8
million at December 31, 2004. Sales for the first nine months of
2005 totaled $10.4 million compared to $13.3 million for the same
period in 2004. Net loss for the first nine months of 2005 was
$2,621,737, or ($0.36) per common (diluted) share, on 7.2 million
shares outstanding, compared to a net loss of $1,909,963, or
($0.28) per common (diluted) share, on 6.7 million shares
outstanding, in the year 2004. AMS Health Sciences, Inc., sells
more than 60 natural nutritional supplements, weight management
products, and natural skincare products through independent
distributors across the U.S. and Canada. More information about the
Company is available at http://www.amsonline.com
Grafico Azioni Safety First Trust Principal-Protected Trust Certificates Linked TO The S&P 500 Index (AMEX:AMM)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Safety First Trust Principal-Protected Trust Certificates Linked TO The S&P 500 Index (AMEX:AMM)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Safety First Trust Principal-Protected Trust Certificates Linked TO The S&P 500 Index (Borsa Americana (AMEX)): 0 articoli recenti
Più AMS Health Sciences, Inc. Articoli Notizie